Do analysts rate FOXX or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Foxx Development 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, FOXX or AIMD?

Foxx Development has higher revenue and earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Foxx Development $65.92M 0.31 -$9.02M -$6.87 N/A Ainos $120K 89.18 -$14.77M -$2.52 N/A

Is FOXX or AIMD more profitable?

Foxx Development has a net margin of -79.80% compared to Ainos' net margin of -11,912.10%. Foxx Development's return on equity of 0.00% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Foxx Development -79.80% N/A -59.35% Ainos -11,912.10% -217.50% -67.87%

Do analysts rate EBON or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, EBON or AIMD?

Ebang International has higher revenue and earnings than Ainos. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.23 -$14.09M N/A N/A Ainos $120K 89.18 -$14.77M -$2.52 N/A

Do analysts recommend QCLS or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mymd Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is QCLS or AIMD more profitable?

Mymd Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Mymd Pharmaceuticals' return on equity of -91.64% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Mymd Pharmaceuticals N/A -91.64% -47.48% Ainos -11,912.10% -217.50% -67.87%

Do analysts rate AIMD or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AIMD or TNFA more profitable?

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Ainos -11,912.10% -217.50% -67.87% TNF Pharmaceuticals N/A -69.21% -33.98%

Do analysts rate BOXL or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boxlight 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, BOXL or AIMD?

Ainos has lower revenue, but higher earnings than Boxlight. Ainos is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Boxlight $109.25M 0.04 -$23.81M -$80.86 N/A Ainos $120K 89.18 -$14.77M -$2.52 N/A

Is BOXL or AIMD more profitable?

Boxlight has a net margin of -20.96% compared to Ainos' net margin of -11,912.10%. Boxlight's return on equity of 0.00% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Boxlight -20.96% N/A -23.50% Ainos -11,912.10% -217.50% -67.87%

Does the media prefer BOXL or AIMD?

In the previous week, Boxlight had 1 more articles in the media than Ainos. MarketBeat recorded 3 mentions for Boxlight and 2 mentions for Ainos. Ainos' average media sentiment score of 0.40 beat Boxlight's score of 0.00 indicating that Ainos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boxlight 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ainos 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Ainos (AIMD) Competitors

$1.45 +0.06 (+4.32%)

Closing price 08/25/2026 04:00 PM Eastern

Extended Trading

$1.44 -0.01 (-1.03%)

As of 08/25/2026 04:10 PM Eastern

Compare

AIMD vs. FOXX, EBON, QCLS, TNFA, and BOXL

Should you buy Ainos stock or one of its competitors? Ainos's main competitors and comparable companies include Foxx Development (FOXX), Ebang International (EBON), Mymd Pharmaceuticals (QCLS), TNF Pharmaceuticals (TNFA), and Boxlight (BOXL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does Ainos compare to Foxx Development?

Foxx Development (NASDAQ:FOXX) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

60.4% of Foxx Development shares are held by institutional investors. 31.6% of Foxx Development shares are held by company insiders. Comparatively, 9.8% of Ainos shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Foxx Development has a net margin of -79.80% compared to Ainos' net margin of -11,912.10%. Foxx Development's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Foxx Development	-79.80%	N/A	-59.35%
Ainos	-11,912.10%	-217.50%	-67.87%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Foxx Development	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ainos had 1 more articles in the media than Foxx Development. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Foxx Development. Ainos' average media sentiment score of 0.40 beat Foxx Development's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company	Overall Sentiment
Foxx Development	Neutral
Ainos	Neutral

Foxx Development has a beta of -0.35, indicating that its share price is 135% less volatile than the broader market. Comparatively, Ainos has a beta of 2.46, indicating that its share price is 146% more volatile than the broader market.

Foxx Development has higher revenue and earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Foxx Development	$65.92M	0.31	-$9.02M	-$6.87	N/A
Ainos	$120K	89.18	-$14.77M	-$2.52	N/A

Summary

Foxx Development beats Ainos on 8 of the 13 factors compared between the two stocks.

How does Ainos compare to Ebang International?

Ebang International (NASDAQ:EBON) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Ebang International has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Ebang International's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Ainos	-11,912.10%	-217.50%	-67.87%

In the previous week, Ainos had 1 more articles in the media than Ebang International. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Ebang International. Ainos' average media sentiment score of 0.40 beat Ebang International's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company	Overall Sentiment
Ebang International	Neutral
Ainos	Neutral

Ebang International has higher revenue and earnings than Ainos.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.23	-$14.09M	N/A	N/A
Ainos	$120K	89.18	-$14.77M	-$2.52	N/A

Ebang International has a beta of 3, suggesting that its share price is 200% more volatile than the broader market. Comparatively, Ainos has a beta of 2.46, suggesting that its share price is 146% more volatile than the broader market.

1.2% of Ebang International shares are held by institutional investors. 25.4% of Ebang International shares are held by insiders. Comparatively, 9.8% of Ainos shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Ebang International beats Ainos on 8 of the 11 factors compared between the two stocks.

How does Ainos compare to Mymd Pharmaceuticals?

Mymd Pharmaceuticals (NASDAQ:QCLS) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Mymd Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Mymd Pharmaceuticals' return on equity of -91.64% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%
Ainos	-11,912.10%	-217.50%	-67.87%

In the previous week, Ainos had 1 more articles in the media than Mymd Pharmaceuticals. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Mymd Pharmaceuticals. Mymd Pharmaceuticals' average media sentiment score of 1.89 beat Ainos' score of 0.40 indicating that Mymd Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Mymd Pharmaceuticals	Very Positive
Ainos	Neutral

Mymd Pharmaceuticals has higher earnings, but lower revenue than Ainos. Mymd Pharmaceuticals is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mymd Pharmaceuticals	N/A	N/A	-$11.63M	-$3.48	N/A
Ainos	$120K	89.18	-$14.77M	-$2.52	N/A

9.6% of Mymd Pharmaceuticals shares are held by institutional investors. 0.9% of Mymd Pharmaceuticals shares are held by insiders. Comparatively, 9.8% of Ainos shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Mymd Pharmaceuticals has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market. Comparatively, Ainos has a beta of 2.46, suggesting that its stock price is 146% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mymd Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Mymd Pharmaceuticals and Ainos tied by winning 6 of the 12 factors compared between the two stocks.

How does Ainos compare to TNF Pharmaceuticals?

Ainos (NASDAQ:AIMD) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 9.8% of Ainos shares are owned by insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Ainos had 2 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 2 mentions for Ainos and 0 mentions for TNF Pharmaceuticals. Ainos' average media sentiment score of 0.40 beat TNF Pharmaceuticals' score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Neutral
TNF Pharmaceuticals	Neutral

Ainos has higher revenue and earnings than TNF Pharmaceuticals. Ainos is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$120K	89.18	-$14.77M	-$2.52	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

Ainos has a beta of 2.46, suggesting that its share price is 146% more volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market.

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	-11,912.10%	-217.50%	-67.87%
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Ainos beats TNF Pharmaceuticals on 7 of the 12 factors compared between the two stocks.

How does Ainos compare to Boxlight?

Boxlight (NASDAQ:BOXL) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

In the previous week, Boxlight had 1 more articles in the media than Ainos. MarketBeat recorded 3 mentions for Boxlight and 2 mentions for Ainos. Ainos' average media sentiment score of 0.40 beat Boxlight's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boxlight	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ainos	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Boxlight has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Ainos has a beta of 2.46, meaning that its stock price is 146% more volatile than the broader market.

Boxlight has a net margin of -20.96% compared to Ainos' net margin of -11,912.10%. Boxlight's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boxlight	-20.96%	N/A	-23.50%
Ainos	-11,912.10%	-217.50%	-67.87%

6.5% of Boxlight shares are held by institutional investors. 15.4% of Boxlight shares are held by company insiders. Comparatively, 9.8% of Ainos shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boxlight	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ainos has lower revenue, but higher earnings than Boxlight. Ainos is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boxlight	$109.25M	0.04	-$23.81M	-$80.86	N/A
Ainos	$120K	89.18	-$14.77M	-$2.52	N/A

Summary

Boxlight beats Ainos on 8 of the 13 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIMD vs. The Competition

Export

Metric	Ainos	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$10.26M	$112.76B	$28.90B	$12.72B
Dividend Yield	N/A	1.75%	2.75%	11.02%
P/E Ratio	-0.58	29.82	71.98	24.14
Price / Sales	89.18	90.21	593.88	101.63
Price / Cash	N/A	20.08	48.39	53.12
Price / Book	3.30	7.74	9.35	6.25
Net Income	-$14.77M	$3.57B	$676.63M	$347.86M
7 Day Performance	-2.03%	2.52%	0.73%	0.98%
1 Month Performance	3.57%	8.12%	4.44%	5.24%
1 Year Performance	-64.72%	95.99%	188.19%	17.04%

Ainos Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIMD Ainos	0.6071 of 5 stars	$1.45 +4.3%	N/A	-62.2%	$10.26M	$120K	N/A	40	Gap Up
FOXX Foxx Development	0.2482 of 5 stars	$2.94 +2.4%	N/A	-56.3%	$20.70M	$65.92M	N/A	N/A	Gap Down
EBON Ebang International	0.4703 of 5 stars	$2.21 +6.3%	N/A	-40.8%	$14.45M	$6.54M	N/A	260	Gap Down
QCLS Mymd Pharmaceuticals	0.5745 of 5 stars	$2.72 +1.1%	N/A	N/A	$11.34M	N/A	N/A	6	Positive News
TNFA TNF Pharmaceuticals	N/A	$2.69 flat	N/A	-64.8%	$4.97M	N/A	N/A	6

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIMD) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ainos (AIMD) Competitors

AIMD vs. FOXX, EBON, QCLS, TNFA, and BOXL

How does Ainos compare to Foxx Development?

Summary

How does Ainos compare to Ebang International?

Summary

How does Ainos compare to Mymd Pharmaceuticals?

Summary

How does Ainos compare to TNF Pharmaceuticals?

Summary

How does Ainos compare to Boxlight?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIMD vs. The Competition

Ainos Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ainos (AIMD) Competitors

AIMD vs. FOXX, EBON, QCLS, TNFA, and BOXL

How does Ainos compare to Foxx Development?

Do insiders and institutionals have more ownership in FOXX or AIMD?

Is FOXX or AIMD more profitable?

Do analysts rate FOXX or AIMD?

Does the media favor FOXX or AIMD?

Which has more risk & volatility, FOXX or AIMD?

Which has higher valuation and earnings, FOXX or AIMD?

Summary

How does Ainos compare to Ebang International?

Is EBON or AIMD more profitable?

Does the media favor EBON or AIMD?

Which has better earnings and valuation, EBON or AIMD?

Which has more risk and volatility, EBON or AIMD?

Do institutionals & insiders believe in EBON or AIMD?

Do analysts rate EBON or AIMD?

Summary

How does Ainos compare to Mymd Pharmaceuticals?

Is QCLS or AIMD more profitable?

Does the media favor QCLS or AIMD?

Which has preferable earnings & valuation, QCLS or AIMD?

Do insiders and institutionals believe in QCLS or AIMD?

Which has more volatility & risk, QCLS or AIMD?

Do analysts recommend QCLS or AIMD?

Summary

How does Ainos compare to TNF Pharmaceuticals?

Do institutionals & insiders believe in AIMD or TNFA?

Does the media prefer AIMD or TNFA?

Which has preferable earnings and valuation, AIMD or TNFA?

Which has more volatility and risk, AIMD or TNFA?

Is AIMD or TNFA more profitable?

Do analysts rate AIMD or TNFA?

Summary

How does Ainos compare to Boxlight?

Does the media prefer BOXL or AIMD?

Which has more volatility and risk, BOXL or AIMD?

Is BOXL or AIMD more profitable?

Do institutionals & insiders believe in BOXL or AIMD?

Do analysts rate BOXL or AIMD?

Which has stronger earnings and valuation, BOXL or AIMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIMD vs. The Competition

Ainos Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools